AwardApr 21, 2026, 01:00 PM
Royalty Pharma Launches $1M Translational Prize for Scientists
AI Summary
Royalty Pharma plc announced the launch of the Royalty Pharma Translational Prize, an annual award designed to recognize exceptional achievements in translational medicine. The prize aims to honor scientific breakthroughs that successfully bridge fundamental discovery with the development of new medicines, particularly contributions not yet widely recognized. It includes a $1 million award for established scientists whose work has significantly impacted patient lives.
Key Highlights
- Royalty Pharma launched the Royalty Pharma Translational Prize.
- The annual prize includes a $1 million award for scientists.
- It recognizes exceptional achievements in translational medicine.
- Nominations open in summer 2026, with the first laureate in spring 2027.
- The independent committee will be chaired by Nobel Laureate Sir Gregory Winter.
Price Impact
More from RPRX